BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36398772)

  • 1. Preoperative blood markers for prediction of recurrence-free survival after surgical treatment of patients with stage III lung adenocarcinoma.
    Tahanovich AD; Kauhanka NN; Murashka DI; Kolb AV; Prokhorova VI; Got'ko OV; Derzhavets LA
    Klin Lab Diagn; 2022 Nov; 67(11):640-646. PubMed ID: 36398772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predicting the risk of tumor progression in patients with early stages of adenocarcinoma and squamous cell lung carcinoma based on laboratory parameters].
    Tahanovich AD; Kauhanka NN; Prohorova VI; Murashka DI; Gotko OV
    Biomed Khim; 2021 Nov; 67(6):507-517. PubMed ID: 34964445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic efficiency of determining CXCR1, CXCR2 and hyaluronic acid blood level in non-small cell lung cancer patients].
    Murashka DI; Tahanovich AD; Kauhanka MM; Prokhorova VI; Gotko OV
    Biomed Khim; 2021 Sep; 67(5):434-442. PubMed ID: 34730557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer.
    Murashka DI; Tahanovich AD; Kauhanka MM; Gotko OV; Prokhorova VI
    Klin Lab Diagn; 2022 May; 67(5):277-285. PubMed ID: 35613346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
    Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung.
    Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY
    Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.
    Sato Y; Fujimoto D; Uehara K; Shimizu R; Ito J; Kogo M; Teraoka S; Kato R; Nagata K; Nakagawa A; Otsuka K; Hamakawa H; Takahashi Y; Imai Y; Tomii K
    BMC Cancer; 2016 Nov; 16(1):890. PubMed ID: 27842505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.
    Aramini B; Casali C; Stefani A; Bettelli S; Wagner S; Sangale Z; Hughes E; Lanchbury JS; Maiorana A; Morandi U
    Lung Cancer; 2016 Nov; 101():82-87. PubMed ID: 27794412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence.
    Isaksson S; George AM; Jönsson M; Cirenajwis H; Jönsson P; Bendahl PO; Brunnström H; Staaf J; Saal LH; Planck M
    Acta Oncol; 2019 Aug; 58(8):1079-1086. PubMed ID: 31230502
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer.
    Niklinski J; Burzykowski T; Niklinska W; Laudanski J; Chyczewski L; Rapellino M; Furman M
    Eur Respir J; 1998 Dec; 12(6):1424-8. PubMed ID: 9877503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
    Liu C; Zhang H; Qi Q; Zhang B; Yue D; Wang C
    Thorac Cancer; 2020 Apr; 11(4):918-927. PubMed ID: 32061027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
    Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
    Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer.
    Niklinski J; Furman M; Chyczewska E; Chyczewski L; Rogowski F; Laudanski J
    Eur Respir J; 1995 Feb; 8(2):291-4. PubMed ID: 7538933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
    Niklinski J; Furman M; Burzykowski T; Chyczewski L; Laudanski J; Chyczewska E; Rapellino M
    Br J Cancer; 1996 Sep; 74(6):956-60. PubMed ID: 8826865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
    Lim JK; Shin KM; Lee HJ; Lee H; Hahm MH; Lee J; Kim CH; Cha SI; Jeong JY; Park TI
    Acad Radiol; 2019 May; 26(5):e21-e31. PubMed ID: 30064921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.